| Dr Michael C Treisman, MD | |
|
91 Florissant Oaks Shop Ctr, Florissant, MO 63031-3934 | |
| (314) 831-8600 | |
| Not Available |
| Full Name | Dr Michael C Treisman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 91 Florissant Oaks Shop Ctr, Florissant, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184685455 | NPI | - | NPPES |
| 110175876 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 105350 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Saint louis, MO | Home health agency |
| Mercy Hospital St Louis | Saint louis, MO | Hospital |
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| St Lukes Hospital | Chesterfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Mercy Clinic East Communities | 7214827922 | 491 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.
For children with Type 1 diabetes, the risk of experiencing a severe hypoglycemic episode is especially common - and for parents, the threat of that happening in the middle of the night is especially frightening.
A research review carried out by the Royal College of Surgeons in Ireland (RCSI) and published in 'Nature Reviews and Drug Discovery' (October 2010) has highlighted the lessons, opportunities and recent developments in the area of drug development for cardiovascular disease, auto-immune disorders and multiple sclerosis.
Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients, according to a new medical position statement and technical review published by the American Gastroenterological Association in its official journal, Gastroenterology.
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.
› Verified 4 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.
For children with Type 1 diabetes, the risk of experiencing a severe hypoglycemic episode is especially common - and for parents, the threat of that happening in the middle of the night is especially frightening.
A research review carried out by the Royal College of Surgeons in Ireland (RCSI) and published in 'Nature Reviews and Drug Discovery' (October 2010) has highlighted the lessons, opportunities and recent developments in the area of drug development for cardiovascular disease, auto-immune disorders and multiple sclerosis.
Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients, according to a new medical position statement and technical review published by the American Gastroenterological Association in its official journal, Gastroenterology.
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael C Treisman, MD 91 Florissant Oaks Shop Ctr, Florissant, MO 63031-3934 Ph: (314) 831-8600 | Dr Michael C Treisman, MD 91 Florissant Oaks Shop Ctr, Florissant, MO 63031-3934 Ph: (314) 831-8600 |
News Archive
A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.
For children with Type 1 diabetes, the risk of experiencing a severe hypoglycemic episode is especially common - and for parents, the threat of that happening in the middle of the night is especially frightening.
A research review carried out by the Royal College of Surgeons in Ireland (RCSI) and published in 'Nature Reviews and Drug Discovery' (October 2010) has highlighted the lessons, opportunities and recent developments in the area of drug development for cardiovascular disease, auto-immune disorders and multiple sclerosis.
Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD. A number of factors contribute to the increase in risk, which necessitates an individualized and sensible approach to surveillance in patients, according to a new medical position statement and technical review published by the American Gastroenterological Association in its official journal, Gastroenterology.
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.
› Verified 4 days ago
Rebecca V Rugen, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Graham Rd, Ste 2320c, Florissant, MO 63031 Phone: 314-953-6801 Fax: 314-953-6819 | |
Dr. Rita Mukerji, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Graham Rd Ste C-2310, Florissant, MO 63031 Phone: 314-953-6300 Fax: 314-953-6309 | |
Dr. Haobin Chen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1255 Graham Rd, Div Im Medical Oncology, Ste 101, Florissant, MO 63031 Phone: 800-647-2098 Fax: 314-362-3192 | |
Jareer Othman Baker Farah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Graham Rd Ste C-2310, Florissant, MO 63031 Phone: 314-953-6300 | |
Felicia R Bentley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 247 Dunn Rd, Florissant, MO 63031 Phone: 314-438-0700 Fax: 314-438-0737 | |
Dr. Francisco J Garriga, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 Shackelford Rd, Florissant, MO 63031 Phone: 314-921-4420 Fax: 314-921-6086 |